Add-on
OPRM1: How Your Genes Shape Opioid Response
All NiaHealth tests are processed in Canadian-certified labs, which are highly trusted by the medical community for their accuracy and reliability. Blood and urine samples are collected by licensed medical professionals and processed using state-of-the-art equipment. NiaHealth is SOC2 Type 2 certified.
OPRM1 provides instructions for making the μ-opioid receptor, the main target for opioid medications. Genetic variants may influence how strongly a person responds to opioids, including how much pain relief they experience. Evidence is still evolving, and results may help inform monitoring and expectations, but are not used to guide prescribing decisions.
Available as an add-on
OPRM1 is part of our Pharmacogenetic Test add-on, starting from $799.
Nurse Practitioner reviewed
Canadian-certified labs
SOC2 Type 2 certified
Why it matters
Reference ranges
This information is educational and does not replace medical advice, diagnosis, or treatment. Your results should be interpreted with a qualified healthcare professional in the context of your health history.
